TrialPath

19 studies

Recruiting now, in plain language. Every study is watched over by an independent ethics board.

13 studies on the map

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity — University of Alabama Saint Vincent's Birmingham, BirminghamSotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease — Stanford University Medical Center, StanfordPiMZ Longitudinal Cohort (PiMZ Logic) — University of Alabama at Birmingham, BirminghamKidney Health: Eat Well, Live Well — Harris Health System's Outpatient Center, HoustonNew Heart Imaging Techniques to Evaluate Possible Heart Disease — National Institutes of Health Clinical Center, BethesdaPrevention of Progression of Prediabetes, Obesity and CV Risk — University of Texas Health Science Center at San Antonio, San AntonioMechanism of SGLT2 Inhibition in the Kidney — University of Michigan, Ann ArborPrevalence of Gastric Motor Dysfunction and Upper GI Symptoms in Gastric Antral Vascular Ectasias — Mayo Clinic, RochesterEnhancing Physical Function in Older Adults With Chronic Kidney Disease — Wake Forest University Health Sciences, Winston-SalemFeasibility of the SCD in Cardiorenal Syndrome Patients Awaiting LVAD — University of Michigan, Ann ArborInter-lobar Fissure Completion in Patients With Failed Bronchoscopic Lung Volume Reduction — Beth Israel Deaconess Medical Center, BostonNeurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD — John D. Dingell VA Medical Center, Detroit, MI, DetroitNHALES (Natural History of Asthma With Longitudinal Environmental Sampling) — NIEHS Clinical Research Unit (CRU), Research Triangle Park